5F-AB-FUPPYCA

From WikiMD's WELLNESSPEDIA

5F-AB-FUPPYCA.svg

Synthetic cannabinoid

5F-AB-FUPPYCA





Chemical nomenclature
IUPAC name 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrazole-3-carboxamide


















Chemical data


Chemical formula C20H26N3O1F1






5F-AB-FUPPYCA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system.

Chemical Structure[edit]

5F-AB-FUPPYCA belongs to the class of pyrazole-based synthetic cannabinoids. Its chemical structure includes a 5-fluoropentyl chain, a pyrazole ring, and a carboxamide group. The IUPAC name for 5F-AB-FUPPYCA is 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrazole-3-carboxamide.

Pharmacology[edit]

As a synthetic cannabinoid, 5F-AB-FUPPYCA acts on the CB1 receptor and CB2 receptor, mimicking the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. The activation of these receptors can lead to various physiological and psychoactive effects.

Legal Status[edit]

The legal status of 5F-AB-FUPPYCA varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use.

Health Risks[edit]

The use of synthetic cannabinoids like 5F-AB-FUPPYCA can pose significant health risks, including tachycardia, hypertension, hallucinations, and psychosis. Due to the lack of clinical studies, the long-term effects of 5F-AB-FUPPYCA are not well understood.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.